Advanced

Advanced technologies and diagnostic spin-outs: an interview with Carl Borrebaeck.

Borrebaeck, Carl LU (2015) In Expert Review of Molecular Diagnostics 15(11). p.1409-1410
Abstract
Interview with Professor Carl Borrebaeck DSc by Claire Raison (Commissioning Editor) Professor Carl Borrebaeck DSc, is the Director of CREATE Health (Lund, Sweden), a translational cancer center, previous Vice President of Lund University and specializes in immunotechnology, diagnostics and treatments for cancer. He has had remarkable success in co-founding collaborative working groups and related spin-out companies based in Lund. Professor Borrebaeck also serves as a member of the editorial advisory board for Expert Review of Molecular Diagnostics. Here, Professor Borrebaeck talks to Expert Review of Molecular Diagnostics about his experience and what is next for cutting-edge technology in cancer diagnostics.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Expert Review of Molecular Diagnostics
volume
15
issue
11
pages
1409 - 1410
publisher
Future Drugs Ltd
external identifiers
  • pmid:26465682
  • wos:000364630600002
  • scopus:84947127390
ISSN
1744-8352
DOI
10.1586/14737159.2015.1100499
language
English
LU publication?
yes
id
2cdfc040-76a2-4ae0-80fb-7bd36018b005 (old id 8152368)
date added to LUP
2015-11-13 12:59:57
date last changed
2017-01-01 04:19:15
@misc{2cdfc040-76a2-4ae0-80fb-7bd36018b005,
  abstract     = {Interview with Professor Carl Borrebaeck DSc by Claire Raison (Commissioning Editor) Professor Carl Borrebaeck DSc, is the Director of CREATE Health (Lund, Sweden), a translational cancer center, previous Vice President of Lund University and specializes in immunotechnology, diagnostics and treatments for cancer. He has had remarkable success in co-founding collaborative working groups and related spin-out companies based in Lund. Professor Borrebaeck also serves as a member of the editorial advisory board for Expert Review of Molecular Diagnostics. Here, Professor Borrebaeck talks to Expert Review of Molecular Diagnostics about his experience and what is next for cutting-edge technology in cancer diagnostics.},
  author       = {Borrebaeck, Carl},
  issn         = {1744-8352},
  language     = {eng},
  number       = {11},
  pages        = {1409--1410},
  publisher    = {Future Drugs Ltd},
  series       = {Expert Review of Molecular Diagnostics},
  title        = {Advanced technologies and diagnostic spin-outs: an interview with Carl Borrebaeck.},
  url          = {http://dx.doi.org/10.1586/14737159.2015.1100499},
  volume       = {15},
  year         = {2015},
}